# DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option

Source: https://welltoldgrants.com/grants/ht942525prcrpcdafro-dod-peer-reviewed-cancer-career-development-award-fellow/  
Official notice: https://www.grants.gov/search-results-detail/359094

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 12 awards worth $6.7 million in total. Applications closed on July 3, 2025.

| Field | Value |
|---|---|
| Opportunity number | HT942525PRCRPCDAFRO |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | July 3, 2025 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 12 |
| Total funding | $6.7 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

Summary: The fiscal year 2025 (FY25) Peer Reviewed Cancer Research Program (PRCRP) Clinical Development Award - Fellow and Resident Option (CDA-FRO) supports the advancement of cancer research through development of early-career investigators. Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. The proposed research should address a critical problem in at least one of the FY25 PRCRP topic areas and at least one of the FY25 PRCRP strategic goals and should be designed to advance cancer research and/or improve patient care. Distinctive Features: There are two distinct early-career development options: the Fellow Option and the Resident Option. For the Fellow Option the PI must be an early-career researcher or physician-scientist (referred to as a Fellow) within seven years after completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training or on family medical leave). For the Resident Option the PI must be an early-career clinician performing their residency with an interest in becoming a physician-scientist. Career Guide: Inclusion of a Career Guide, experienced cancer researcher, as demonstrated by a strong record of funding and publications, is required for both the Fellow Option and the Resident Option. The Career Guide must demonstrate a commitment to advancing the PI’s career in cancer research. Funding Details: (New for FY25) Funding limits are now listed as total cost limits, which is the combination of both direct and indirect costs.

## Questions people ask

### Is HT942525PRCRPCDAFRO still open?

No. It closed on July 3, 2025. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option?

Closed July 3, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $6.7 million in total across about 12 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.